|
MechanismmAChRs antagonists |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date11 May 1950 |
100 Clinical Results associated with Aptalis Pharma US, Inc.
0 Patents (Medical) associated with Aptalis Pharma US, Inc.
100 Deals associated with Aptalis Pharma US, Inc.
100 Translational Medicine associated with Aptalis Pharma US, Inc.